A. Jeffrey Radov, Director at BioRestorative Therapies, Inc. (BRTX), bought 9,000 shares at $0.27 ($2K) on 2019-08-27, disclosed to the SEC on 2019-08-29.
Open-market purchase of $2k BRTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.27 | 3,000 | $810 | 32.9% |
| 2 | $0.27 | 3,000 | $810 | 32.9% |
| 3 | $0.28 | 3,000 | $840 | 34.2% |
| Total | $0.27 avg | 9,000 | $2K | 100% |